Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Auditor change
Employment agrmnt
Quarterly results
Appointed director
CC transcript
|
|
YIELD10 BIOSCIENCE, INC. (YTEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/18/2021 |
GN
| Yield10 Bioscience to Present at the Benzinga Biotech Small Cap Conference on March 25, 2021 |
| 03/16/2021 |
GN
| Yield10 Bioscience Announces Fourth Quarter and Full Year 2020 Financial Results |
| 03/09/2021 |
GN
| Yield10 Bioscience to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call on Tuesday, March 16, 2021 |
| 03/01/2021 |
GN
| Yield10 Bioscience to Present at Bank of America 2021 Virtual Global Agriculture & Materials Conference on March 4, 2021 |
| 02/19/2021 |
GN
| Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million |
| 02/03/2021 |
GN
| Yield10 Bioscience Announces Closing of $12.7 Million Public Offering |
| 01/31/2021 |
GN
| Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering |
| 01/29/2021 |
GN
| Yield10 Bioscience Announces Proposed Public Offering of Common Stock |
| 10/28/2020 |
GN
| Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties |
| 10/01/2020 |
GN
| Yield10 Bioscience Announces Completion of Harvesting for 2020 Field Test Program to Evaluate Novel Yield and Compositional Traits in Camelina and Canola |
| 08/26/2020 |
GN
| Yield10 Bioscience Announces Closing of $4.0 Million Public Offering, Including Exercise of the Over-Allotment Option, and Concurrent $1.7 Million Private Placement |
| 08/22/2020 |
GN
| Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement |
| 08/21/2020 |
GN
| Yield10 Bioscience Announces Proposed Public Offering of Common Stock and Concurrent Private Placement |
| 08/17/2020 |
GN
| Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021 |
| 08/11/2020 |
GN
| Yield10 Bioscience Signs Research Agreement with GDM to Evaluate New Yield Traits in Soybean |
| 08/06/2020 |
GN
| Yield10 Bioscience to Announce Second Quarter 2020 Financial Results and Host a Conference Call on Tuesday, August 11, 2020 |
| 08/05/2020 |
GN
| Yield10 Bioscience Announces Spring Planting of 50 Acres of Wild-Type Spring Camelina to Support Business Development Plans |
| 06/17/2020 |
GN
| Yield10 Bioscience Begins 2020 Field Test Program to Evaluate Novel Yield Traits in Camelina and Canola |
| 05/14/2020 |
GN
| Yield10 Bioscience Announces First Quarter 2020 Financial Results |
| 05/14/2020 |
GN
| Yield10 Bioscience Secures Regulatory Permits for U.S. and Canadian Sites and Announces Plans for 2020 Field Test Program in Camelina and Canola |
| 05/13/2020 |
GN
| Yield10 Bioscience to Announce First Quarter 2020 Financial Results and Host a Conference Call on Thursday, May 14, 2020 |
| 05/06/2020 |
GN
| Yield10 Bioscience Announces Change of 2020 Annual Meeting of Stockholders to a Virtual Meeting |
| 03/19/2020 |
GN
| Yield10 Bioscience Announces Fourth Quarter and Full Year 2019 Financial Results |
| 03/19/2020 |
GN
| Yield10 Bioscience Announces Results of 2019 Field Test Program |
| 03/12/2020 |
GN
| Yield10 Bioscience to Announce Fourth Quarter and Full Year 2019 Financial Results and Host a Conference Call on Thursday, March 19, 2020 |
| 03/10/2020 |
GN
| Yield10 Bioscience Achieves Key Milestones in Early Development Program in Corn to Evaluate Novel Traits |
| 01/31/2020 |
GN
| Yield10 Bioscience Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement |
| 01/16/2020 |
GN
| Yield10 Bioscience Submits "Am I Regulated?" Letter to USDA-APHIS BRS for CRISPR Genome-Edited C3007 in Camelina to Pave the Way for U.S. Field Tests |
| 01/15/2020 |
GN
| Yield10 Bioscience Announces 1-for-40 Reverse Stock Split |
| 11/19/2019 |
GN
| Yield10 Bioscience Announces Closing of $11.5 Million Equity Offering and Full Exercise of Over-allotment Option |
| 11/15/2019 |
GN
| Yield10 Bioscience Announces Pricing of $10.75 Million Equity Offering |
| 11/12/2019 |
GN
| Yield10 Bioscience Announces Third Quarter 2019 Financial Results |
| 11/05/2019 |
GN
| Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the 7th Plant Genomics & Gene Editing Congress |
| 08/19/2019 |
GN
| Yield10 Bioscience Expands Research License with Bayer for Evaluation of a Novel C3004 Yield Trait Gene in Soybean |
|
|
|